Tarriff Scott sold EGRX
February 28, 2024 · Form 4 insider transaction
Tarriff Scott sold 2,119 shares of Eagle Pharmaceuticals, Inc. at $6.27 per share, a transaction worth $13.3K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,119
Price
$6.27
Total value
$13.3K
InsiderTarriff Scott
Role10% owner
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 28, 2024
Filing dateMarch 1, 2024
Shares owned after460,621
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units on February 28, 2024.